The global psoriatic arthritis market size was estimated at USD 11.35 billion in 2024 and is projected to reach USD 19.91 billion by 2030, growing at a CAGR of 9.8% from 2025 to 2030. The new product launches, promising pipeline, a significant rise in consumer awareness, and increasing disease burden are some factor... Read More »
July 2025The U.S. antibiotics market size was estimated at USD 13.77 billion in 2024 and is projected to reach USD 16.46 billion by 2030, growing at a CAGR of 3.0% from 2025 to 2030. The growing prevalence of infectious diseases is a major factor contributing to market growth. The increasing prev... Read More »
July 2025The U.S. personalized vitamins market size was estimated at USD 1.67 billion in 2024 and is projected to reach USD 5.29 billion by 2033, growing at a CAGR of 14.32% from 2025 to 2033.This growth is driven by increasing consumer awareness of health and wellness... Read More »
July 2025The U.S. Shingles Vaccine market size was valued at USD 3.41 billion in 2024 and is projected to register a CAGR of 10.17% during 2025 - 2033. Growth in the market is primarily driven by the expanding elderly population, increased awareness of shingles-related complications, and the broa... Read More »
July 2025The U.S. anti-venom market size was estimated at USD 424.5 million in 2024 and is projected to reach USD 670.0 million by 2030, growing at a CAGR of 8.0% from 2025 to 2030. The market is expanding due to the rising incidence of venomous bites and stings, especially from snakes and insect... Read More »
July 2025The U.S. acromegaly treatment market size was estimated at USD 571.3 million in 2024 and is projected to reach USD 977.2 million by 2033, growing at a CAGR of 6.2% from 2025 to 2033. This is attributed to the rising prevalence of acromegaly and earlier diagnoses, coupled with advancement... Read More »
July 2025The global eliquis (apixaban) market size was valued at USD 20.7 billion in 2024 and is projected to grow from USD 24.2 billion in 2026 to USD 18.9 billion by 2033, at a CAGR of -2.2% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 32.6% in 2024.,... Read More »
July 2025The U.S. antibody drug conjugates market size was valued at USD 7.15 billion in 2024 and is projected to reach USD 10.60 billion by 2030, growing at a CAGR of 4.9% from 2025 to 2030. This can be attributed to the increasing incidence of cancer cases and increased demand for low-tox... Read More »
July 2025The U.S. lysosomal storage disease treatment market size was estimated at USD 1.41 billion in 2024 and is projected to reach USD 1.99 billion by 2033, growing at a CAGR of 4.10% from 2025 to 2033. The rising prevalence of rare genetic disorders, better diagnostic capabilities, and broader access to enzyme replacemen... Read More »
July 2025The U.S. antifungal drugs market was estimated at USD 6.05 billion in 2024 and is projected to reach USD 7.20 billion by 2030, growing at a CAGR of 3.0% from 2025 to 2030. The growing incidence of fungal infections drives market expansion. Fungal infections cover a broad range of conditi... Read More »
July 2025The U.S. anti-pollution nasal spray market size was estimated at USD 2.29 billion in 2024 and is projected to reach USD 2.80 billion by 2030, growing at a CAGR of 3.4% from 2025 to 2030. Globally, high air pollution levels, driven by industrialization, urbanization, and rising vehicular ... Read More »
July 2025The U.S. Astaxanthin market size was estimated at USD 531.11 million in 2024 and is projected to reach USD 1,684.45 million by 2033, growing at a CAGR of 13.58% from 2025 to 2033, primarily driven by innovations in microencapsulation that enhance bioavailability. Astaxanthin, a potent ca... Read More »
July 2025The U.S. antiviral drugs market size was estimated at USD 26.41 billion in 2024 and is projected to reach USD 23.61 billion by 2030, growing at a CAGR of -1% from 2025 to 2030. This decline is largely due to the waning demand for COVID-19-specific antivirals, as the number of severe COVI... Read More »
July 2025The U.S. antibiotic resistance market size was estimated at USD 3.09 billion in 2024 and is projected to reach USD 3.99 billion by 2030, growing at a CAGR of 4.4% from 2025 to 2030. The market is expected to grow, driven by the rising misuse and overuse of antibiotics. According to the C... Read More »
July 2025The U.S. attention deficit hyperactivity disorder market size was estimated at USD 10.31 billion in 2024 and is projected to reach USD 13.88 billion by 2033, growing at a CAGR of 3.3% from 2025 to 2033. The market is primarily driven by a continuous increase in diagnosed cases, supported... Read More »
July 2025The U.S. antacids market size was estimated at USD 3.00 billion in 2024 and is projected to reach USD 3.73 billion in 2030, growing at a CAGR of 3.7% from 2025 to 2030. Changing dietary habits is a key factor propelling market growth over the forecast period. Rising cases of digestive is... Read More »
July 2025The U.S. erleada market size was estimated at USD 1.28 billion in 2024 and is projected to reach USD 2.5 billion by 2033, registering a CAGR of 7.44% from 2025 to 2033. Growth is driven by rising prostate cancer prevalence, increasing adoption of novel hormonal therapies, and favora... Read More »
July 2025The global erleada market size was valued at USD 3.0 billion in 2024 and is projected to grow from USD 3.9 billion in 2026 to USD 6.1 billion by 2033, at a CAGR of 8.0% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 65.0% in 2024. The erlead... Read More »
July 2025The U.S. dupixent market size was estimated at USD 10.39 billion in 2024 and is projected to reach USD 16.82 billion by 2033, growing at a CAGR of 5.47% from 2025 to 2033. The market growth dominates due to high healthcare access in the U.S. The U.S. dupixent industry is driven by t... Read More »
July 2025The U.S. diabetic ketoacidosis treatment market size was estimated at USD 261.43 million in 2024 and is projected to reach USD 374.39 million by 2033, growing at a CAGR of 4.07% from 2025 to 2033. This growth is driven by the increasing incidence of type 1 and insulin-dependent type 2 di... Read More »
July 2025